Vir Biotechnology Inc (VIR) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vir Biotechnology Inc   (NASDAQ: VIR)


Vir Biotechnology Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vir Biotechnology Inc's ROI in the second quarter of 2026?
Vir Biotechnology Inc recorded a cumulative net loss of $-252 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -25.87%.

Within the Healthcare sector 330 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3482 to 3641.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -20.89 % -27.95 % -30.69 % -30 % -28.73 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,085 952 910 944 1,088
Return On Investment (TTM) -25.87 % -45.48 % -42.6 % -44.6 % -44.75 %
VIR's Overall Ranking # 3641 # 3482 # 2692 # 3214 # 2959
Seq. Investment Change TTM -0.07 % -5.31 % -8.24 % -8.88 % -8.99 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -252 -443 -438 -500 -550

VIR Company Profile >> Back to VIR Roi Comparisons >> See Annual VIR Return On Investment



Return On Investment VIR's Ranking
Within: No.
Industry # 36
Sector # 331
Overall # 3641

Return On Investment Statistics
High Average Low
85.55 %
-19.11 %
-53.58 %
(Mar 31 2022)   (Dec 31 2019)







Financial Statements
Vir Biotechnology Inc's II. Quarter Investments $ 1,085 Millions VIR's Balance sheet
Vir Biotechnology Inc's II. Quarter Income $ 80 Millions Quarterly VIR's Income Statement
VIR's Income by Division See VIR's Income by Division


VIR Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 910 1,279 1,744 2,291 1,461
Y / Y Investment Growth -28.86 % -26.64 % -23.89 % 56.81 % 94.83 %
Net Income in Millions -438 -522 -615 516 529
Y / Y Net Income Growth - - - -2.41 % -
Annual Return On Investment -48.13 % -40.81 % -35.27 % 22.52 % 36.18 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VIR's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VIR's Competitors
Subscribers only: Roi for Vir Biotechnology Inc's Suppliers
Subscribers only: Return On Investment for VIR's Customers

Other Ratios
VIR's Roa VIR's Inventory Turnover Ratio VIR's Growth Rates VIR's Dividend Statistics
VIR's Profitability Ratios VIR's Asset Turnover Ratio VIR's Dividend Growth
VIR's Roe VIR's Valuation Ratios VIR's Financial Strength Ratios VIR's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T22:46:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.